Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-05-26 @ 6:05 AM
Study NCT ID:
NCT01239758
Status:
TERMINATED
Last Update Posted:
2013-02-01
First Post:
2010-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy
Sponsor:
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Duchenne Muscular Dystrophy | View |
Keywords: